Skip to main content
OpenTrials
Completed

NCT Number: NCT04675515

CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients

The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tobacco Use Behavior Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

About this study

This mixed-methods, observational cohort study will assess intensive tobacco treatment with carbon monoxide monitoring offered to all eligible smoking patients presenting for cancer treatment to the NCCC at our main Lebanon campus and our very rural St. Johnsbury campus. Subjects will not be randomized and study will not be blinded. Cessation rates among the intensive tobacco treatment will be compared to usual care, matched historical controls, and to patients who refuse all tobacco treatment program elements.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults age 18 and older
  • Active Smoker at the time of initial consultation for cancer (defined as any smoking within 2 weeks of consult)

Exclusion criteria

  • Adults unable to consent
  • Prisoners

Treatment and study plan

Intensive Tobacco Treatment

Behavioral

Bi-weekly tobacco treatment counseling and regular carbon monoxide monitoring

Primary outcomes

  1. Change is smoking status

    Time frame: 30 days, 3 Months, 6 Months

    Change in smoking status (from smoking to not smoking) of those in an intensive tobacco treatment program at 30 days, 3 months and 6 months

Secondary outcomes

  1. Motivational Impact of real-time carbon monoxide monitoring

    Time frame: 6 Months

    Motivational impact of real-time carbon monoxide monitoring in patients receiving intensive tobacco treatment as determined by a Motivation to Quit Assessment Questionnaire

  2. Engagement Level with Tobacco Treatment via Telehealth

    Time frame: 6 Months

    Level of engagement with tobacco treatment via telehealth compared to historical control face-to-face visits as determined by a Technology Access and Experiences Questionnaire

Other outcomes

  1. Engagement Level With Tobacco Treatment for Low Resource Patients outh!

    Time frame: 6 Months

    Level of engagement with tobacco treatment for low-resource patients who are provided cell phones with data plans as determined by a Technology Access and Experiences Questionnaire

Sponsors and collaborators

Lead sponsor

Dartmouth-Hitchcock Medical Center

Other

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2024
First posted
Dec 19, 2020
Registry last updated
Jul 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.